- ASP Isotopes Inc. (ASPI) is preparing for a **secondary listing on the Johannesburg Stock Exchange (JSE)**, with trading expected to commence on **August 27, 2025**, while retaining its primary Nasdaq listing.  **[1921865_0001477932-25-006215_aspi_8k.htm:1]** 
- The company commenced commercial production of **Silicon-28** in **late March 2025**, shipping its first samples to a US customer in **August 2025**.  **[1921865_0001477932-25-006215_aspi_8k.htm:1]** 
- Commercial production of **Ytterbium-176** began in **April 2025**, with the first batch of final product expected in **late August 2025**; however, the transition to a semi-continuous processing method is delayed to **late Q3 or early Q4 2025**.  **[1921865_0001477932-25-006215_aspi_8k.htm:1]** 
- ASPI is enriching **Carbon-12 to 99.99%** for a US customer, with the first commercial product expected in **September 2025**, following a 10-day delay due to regulatory inspections.  **[1921865_0001477932-25-006215_aspi_8k.htm:2]** 
- The company expects to initiate the spin-out of its subsidiary, Quantum Leap Enrichment (QLE), as a standalone public company in the **second half of 2025**, and anticipates the Renergen acquisition to close during the **third quarter of 2025**.  **[1921865_0001477932-25-006215_aspi_8k.htm:2]**

ASP Isotopes (ASPI)